TRACON Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 118.8%.

Top 16 shareholders own 6.59% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
3.91%	Ikarian Capital, LLC	133,404	US$4.0k	-0.11%	no data
1.05%	Wayne Aaronson	35,846	US$1.1k	0%	no data
0.6%	Charles Theuer	20,321	US$609.6	0%	no data
0.42%	Geode Capital Management, LLC	14,335	US$430.0	0%	no data
0.39%	The Vanguard Group, Inc.	13,138	US$394.1	0%	no data
0.12%	Lincoln Park Capital, LLC	4,071	US$122.1	0%	no data
0.037%	Scott Brown	1,256	US$37.7	0%	no data
0.023%	Brookline Investments, Inc.	767	US$23.0	0%	0.29%
0.018%	Saundra Pelletier	602	US$18.1	0%	no data
0.011%	William LaRue	388	US$11.6	0%	no data
0.0051%	Bonne Adams	175	US$5.3	0%	no data
0.0026%	MCT Investments, LLC	90	US$2.7	0%	no data
0.0015%	Game Plan Financial Advisors, LLC	50	US$1.5	0%	no data
0.0011%	Stephen Worland	38	US$1.1	0%	no data
0.0011%	Martin Mattingly	38	US$1.1	0%	no data
0.0011%	James Twiford	38	US$1.1	0%	no data